MétaCan
Menu
Back to cohort
Record W3209811723 · doi:10.1016/j.gocm.2021.10.001

Royal jelly for genitourinary syndrome of menopause: A randomized controlled trial

2021· article· en· W3209811723 on OpenAlexaff
Vahid Mehrnoush, Fatemeh Darsareh

Bibliographic record

VenueGynecology and Obstetrics Clinical Medicine · 2021
Typearticle
Languageen
FieldAgricultural and Biological Sciences
TopicBee Products Chemical Analysis
Canadian institutionsNOSM University
FundersHormozgan University of Medical Sciences
KeywordsMenopauseGenitourinary systemRandomized controlled trialRoyal jellyMedicineSurgeryInternal medicineBiology

Abstract

fetched live from OpenAlex

Abstract Objective Genitourinary syndrome of menopause is a progressive condition characterized by a decrease in estrogen, which causes bothersome genital symptoms. The purpose of the study was to determine the effect of royal jelly on the genitourinary syndrome of menopause. Materials and methods A randomized controlled trial was carried out from November 2018 to June 2019 in Bandar Abbas, Iran. The trial was registered in the Iranian Registry of Clinical Trials (1RCT20181107041585N1) with the main objective of determining if royal jelly could reduce the genitourinary syndrome of menopausal women. Eligible women were randomly assigned to receive either daily 1g of oral royal jelly or placebo for 8 weeks. The urogenital subscale of the Menopausal Rating Scale was used to determine genitourinary syndrome. Independent samples t -test was used for inter-group comparisons and paired samples t -test for pre-and post-treatment comparisons. Results There were no differences in the severity of sexual problems, bladder complications, or vaginal dryness between groups before intervention. Although the intervention group's bladder complications improved slightly after eight weeks of royal jelly treatment compared to the control group (p ​= ​0.04), there were no significant changes in vaginal dryness, sexual problems, or total urogenital score. The within-group changes (before and after treatment) also showed no differences in urogenital symptoms. Conclusions A daily dose of 1g royal jelly taken orally for 8 weeks did not alleviate menopausal genitourinary syndrome. No serious side effects were observed. To make more reliable decisions about the use and safety of royal jelly in the future, different doses of royal jelly and longer trials are required.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.106
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.103
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.106
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.301
Teacher spread0.269 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueGynecology and Obstetrics Clinical MedicineSame topicBee Products Chemical AnalysisFrench-language works237,207